Hemojuvelin N-terminal mutants reach the plasma membrane but do not activate the hepcidin response

Hemojuvelin positively modulates the iron regulator hepcidin. Mutations of the gene encoding for hemojuvelin cause juvenile hemochromatosis, characterized by hepcidin deficiency and severe iron overload. This study shows that the delayed export and retention in the endoplasmic reticulum of some N-terminal mutants could contribute to the pathogenesis of juvenile hemochromatosis. See related perspective article on page 1441. Background Hemojuvelin is a glycosylphosphatidylinositol-anchored protein, expressed in liver, skeletal muscle and heart. As a co-receptor of bone morphogenetic protein, membrane hemojuvelin positively modulates the iron regulator hepcidin. Mutations of the gene encoding for hemojuvelin cause juvenile hemochromatosis, characterized by hepcidin deficiency and severe iron overload. We have previously shown that several hemojuvelin variants do not efficiently reach the plasma membrane, whereas a few N-terminal mutants localize to the plasma membrane. Design and Methods We studied hemojuvelin mutants of N-terminus (C80R, S85P, G99V, ΔRGD) and GDPH-consensus site for autoproteolysis (A168D, F170S, D172E) transiently expressed in HeLa cells, using electron microscopy, morphometric analysis and binding assays at different time points. Hepcidin activation by wild-type and mutant forms of hemojuvelin was assessed in Hep3B cells transfected with a hepcidin-promoter luciferase-reporter construct. Results S85P, G99V and ΔRGD were localized to plasma membrane 36 hours after transfection, but less efficiently exported than the wild-type protein at earlier (24–30 hours) times. Morphometric analysis clearly documented delayed export and endoplasmic reticulum retention of G99V. C80R was exported without delay. GDPH variants were partially retained in the endoplasmic reticulum and Golgi apparatus, but showed impaired plasma membrane localization. In the hepcidin promoter assay only wild type hemojuvelin was able to activate hepcidin. Conclusions The delayed export and retention in the endoplasmic reticulum of some N-terminal mutants could contribute to the pathogenesis of juvenile hemochromatosis, reducing a prompt response of bone morphogenetic protein. However, independently of their plasma membrane export, all hemojuvelin mutants tested showed no or minimal hepcidin activation.

[1]  R. Chung,et al.  Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. , 2008, Blood.

[2]  P. Rotwein,et al.  Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin. , 2008, American journal of physiology. Cell physiology.

[3]  E. Beutler,et al.  Different regulatory elements are required for response of hepcidin to interleukin‐6 and bone morphogenetic proteins 4 and 9 , 2007, British journal of haematology.

[4]  Elizabeta Nemeth,et al.  Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. , 2007, Blood.

[5]  I. Brun-Heath,et al.  Delayed transport of tissue-nonspecific alkaline phosphatase with missense mutations causing hypophosphatasia. , 2007, European journal of medical genetics.

[6]  Yin Xia,et al.  Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. , 2007, The Journal of clinical investigation.

[7]  L. Silvestri,et al.  Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. , 2007, Blood.

[8]  K. R. Meyers,et al.  Evidence That Inhibition of Hemojuvelin Shedding in Response to Iron Is Mediated through Neogenin* , 2007, Journal of Biological Chemistry.

[9]  F. Scolari,et al.  Defective Intracellular Trafficking of Uromodulin Mutant Isoforms , 2006, Traffic.

[10]  N. Andrews,et al.  Hereditary Hemochromatosis Protein, HFE, Interaction with Transferrin Receptor 2 Suggests a Molecular Mechanism for Mammalian Iron Sensing* , 2006, Journal of Biological Chemistry.

[11]  P. Rotwein,et al.  Complex biosynthesis of the muscle-enriched iron regulator RGMc , 2006, Journal of Cell Science.

[12]  P. Gros,et al.  A novel R416C mutation in human DMT1 (SLC11A2) displays pleiotropic effects on function and causes microcytic anemia and hepatic iron overload. , 2006, Blood cells, molecules & diseases.

[13]  Raymond T Chung,et al.  Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression , 2006, Nature Genetics.

[14]  N. Gregersen,et al.  Protein misfolding disorders: Pathogenesis and intervention , 2006, Journal of Inherited Metabolic Disease.

[15]  C. Deng,et al.  A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. , 2005, Cell metabolism.

[16]  A. West,et al.  Interaction of Hemojuvelin with Neogenin Results in Iron Accumulation in Human Embryonic Kidney 293 Cells* , 2005, Journal of Biological Chemistry.

[17]  S. Arber,et al.  Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. , 2005, The Journal of clinical investigation.

[18]  G. Pinkus,et al.  A mouse model of juvenile hemochromatosis. , 2005, The Journal of clinical investigation.

[19]  C. Camaschella,et al.  New insights into iron homeostasis through the study of non-HFE hereditary haemochromatosis. , 2005, Best practice & research. Clinical haematology.

[20]  J. Barton,et al.  Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. , 2004, Blood.

[21]  Alberto Luini,et al.  Mechanism of constitutive export from the golgi: bulk flow via the formation, protrusion, and en bloc cleavage of large trans-golgi network tubular domains. , 2003, Molecular biology of the cell.

[22]  P. Ramos,et al.  erythropoiesis in Decreased differentiation of erythroid cells exacerbates ineffective , 2008 .

[23]  T. Ganz,et al.  Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. , 2008, Blood cells, molecules & diseases.

[24]  T. Ganz,et al.  Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. , 2005, Blood.

[25]  Marie-Pierre Dubé,et al.  Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis , 2004, Nature Genetics.

[26]  D. Girelli,et al.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis , 2003, Nature Genetics.